Myocardial Infarction Clinical Trial
Official title:
Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation
Regular exercise in patients who have heart disease is highly beneficial and improves quality
of life and survival. Exercise training is considered a core component of cardiac
rehabilitation (CR), which is a multicomponent program delivered to patients who have heart
disease. However, it is severely underutilized because people simply don't have the time or
the resources to travel to a CR centre to attend rehab appointments.
The investigators have developed a novel virtual reality (VR) based CR exercise system
(MedBike). This system consists of an exercise bike attached to a VR world; it makes exercise
engaging and fun. Furthermore, patients can be monitored during exercise remotely over the
internet. The investigators intend to perform a pilot randomized controlled trial in which 10
patients are assigned to the MedBike system and 10 to standard CR. The investigators think
that the MedBike system will increase exercise program compliance by providing an enjoyable
and engaging exercise experience which can be performed in the comfort of one's own home. The
investigators think that this will improve fitness (primary endpoint) in these patients. If
the investigators demonstrate that home based exercise is feasible, the investigators plan a
larger study to prove that it is something that should be broadly implemented in patients
with heart disease.
Background Regular exercise, incorporated as part of a comprehensive cardiac rehabilitation
(CR) program, improves morbidity and mortality in cardiac patients, especially those with
elevated risk profiles. It was reported in a review that exercise decreased all-cause
mortality, cardiac mortality, and non-fatal myocardial infarction by 20 to 25%. Of critical
importance, CR non-participants exhibit a 30% lower survival rate than those who participate.
Even though exercise training is considered a core component of cardiac rehabilitation it is
severely underutilized. The majority of adult patients do not participate in exercise
rehabilitation following cardiac events or cardiac surgery; of those eligible, the completion
rates are 15% to 30%. Factors associated with poor compliance include greater distance from
the hospital, need for transportation (e.g. and parking fees), lack of self motivation, poor
social support, low self-esteem, fear of safety and lack of enjoyment. In order to overcome
these barriers, researchers and clinicians have been turning toward eHealth solutions to
decentralize the CR process, increase accessibility, and potentially increase the comfort and
enjoyment derived from exercise. This approach aligns closely with the American Heart
Association's recommendation that Internet-based techniques be used to improve the CR
experience for both patients and healthcare providers.
The Advanced Man Machine Interface Laboratory (AMMI), University of Alberta has developed a
novel virtual reality (VR) enhanced exercise system (MedBIKE) which provides an engaging and
enjoyable exercise experience while allowing CR patients to exercise in the comfort of their
own home. The system consists of a mountain bike mounted on a wirelessly controlled
resistance machine fed directly into a VR console.
This VR console allows for a heightened exercise experience for the patient by allowing them
to cycle through a virtual landscape. While exercising, the patients are monitored remotely
in real-time by a CR clinician using wireless biometric sensors (electrocardiogram, blood
pressure, and pulse oximetry) and a bidirectional audio-video Internet connection. The
investigators believe that by enhancing the exercise experience, eliminating distance and
transportation issues, and providing ongoing support from key healthcare providers, patient
compliance with the CR exercise program will improve. The MedBIKE has not been tested in a
clinical trial.
Objective and Hypothesis:
To perform a randomized pilot feasibility study to assess the:
1. Feasibility of having CR patients perform home-based exercise with MedBIKE
2. Effectiveness of the MedBIKE system to improve fitness (as measured by exercise
tolerance testing using the Bruce protocol). Since this is a feasibility trial, it will
not be fully powered but the investigators will gain preliminary information for a
sample size calculation (for a larger trial)
3. Effectiveness of the MedBIKE system to improve patient compliance to CR.
The investigators hypothesize that home-based CR using the MedBIKE system is feasible and
will effectively improve fitness and compliance (more frequent exercise sessions and a
greater number of total hours). The latter endpoints may not reach statistical significance
but the investigators plan a larger funding application to Canadian Institute for Health
Research for a properly powered study based upon sample size calculations provided by this
pilot randomized control trial.
Methods Adults (age 18y or older) who have had a recent cardiac event, angioplasty or cardiac
surgery (within 2 weeks) and who have been referred for CR at the Jim Pattison Centre for
Heart Health (JPCHH) will be enrolled in this pilot randomised controlled trial. Consecutive,
consenting subjects will be randomised 1:1 (computer based randomisation through an
independent clinical trials centre to ensure allocation concealment independent of the study
team) to the MedBike system or standard rehabilitation in the JPCHH.
Subjects:
Twenty participants (10 intervention and 10 control) will be enrolled. To avoid enrolling
higher risk subjects that require in-person CR supervision, the investigators will exclude
subjects with a history of heart failure, cardiomyopathy, severe valvular disease or rhythm
disturbances requiring cardioversion. Patients with defibrillators and those unable to
consent, speak English, comprehend study procedures, cycle on a stationary bike, perform a
treadmill test, or access the internet from home will be excluded.
Controls (Standard CR) The standard cardiac rehab program is 8 weeks in duration, with
patients exercising under supervision once per week in the JPCHH. Each session will consist
of 30 minutes of cardiorespiratory exercise at a moderate intensity (60 to 80% of predicted
heart rate max or maximum effort achieved during an exercise tolerance test) and a 5-minute
warm-up and cool down period. Participants will be encouraged to supplement the JPCHH program
with an additional optional 2-3 activity sessions per week to be performed in the home or a
commercial exercise facility, in accordance with the standard therapy protocol of the JCPHH.
No upper limit of training sessions will be set.
Intervention Subjects in the intervention arm will complete the same exercise prescription
assigned to the JPCHH patients (i.e.one session will be scheduled per week for 8 weeks as
described above). MedBIKE patients will also be encouraged to use the MedBIKE an additional
2-3x/week (these are optional training sessions). No upper limit of training sessions will be
set. Scheduled training sessions will be monitored remotely in real-time by a cardiac
rehabilitation clinician from the JPCHH via a bidirectional audio-video feed. Biometric
information (electrocardiogram, blood pressure, pulse oximetry) will be collected in real
time. Monitoring will occur from a clinic room in the JPCHH. Biometric information from the
training sessions will be stored on a secure server located within the Faculty of Medicine
and Dentistry, University of Alberta. A secure, encrypted, HIPAA compliant data transmission
profile will be utilized for patient data transmission, reception and storage.
Additional Care Other elements of protocolized CR including multidisciplinary care will
remain unaltered in both groups. This includes a supervised treadmill test performed upon
admission to, and discharge from, the JPCHH using the Bruce protocol.
Endpoints:
1. Fitness: Measured at baseline and 8wk in the JPCHH using the Bruce protocol exercise
tolerance test. The total time exercised will be determined. For the primary endpoint,
similar to prior studies, the investigators will calculate the proportion of patients
achieving an increase in 1 min from baseline to 8 weeks and compare this proportion
between groups. A 1 min increase corresponds to a 1 to 1.5 metabolic equivalent increase
on the Bruce protocol; this translates to a projected 12% to 50% reduction in mortality.
2. Compliance: by comparing the number of scheduled supervised sessions attended (either in
the JPCHH [controls] or remotely supervised [intervention]), the self-reported total
number exercise sessions participated in, and the cumulative number of hours exercised
by each subject. These latter two endpoints will thus include information collected from
optional exercise sessions.
3. Change in cardiovascular risk factors from baseline to 8wk: blood pressure (BP), A1c,
smoking status, lipids.
Data Collection and Analysis:
Baseline data collection will include age, sex, smoking status, past medical history
including cardiovascular risk factors and disease, height, weight, waist circumference, BP,
A1c, fasting lipid profile, resting heart rate, and Bruce protocol treadmill time. Follow-up
data collection (at 8 weeks) will include updated medical events, weight, waist
circumference, BP, A1c, fasting lipids, resting heart rate, follow-up treadmill time,
self-reported total number of exercise sessions and hours exercised. Continuous variables
will be summarized as means ± standard deviations (SD) and dichotomous variables as counts
and proportions. Continuous outcomes will be compared between study arms using logistic
regression adjusting for age, sex and unbalanced baseline characteristics (including for the
primary endpoint). Linear regression will be used for dichotomous outcomes and Poisson
regression for counts.
Sample Size:
The sample size is low, but this is a feasibility trial. Only one CR session per week will be
supervised; optional CR sessions will be ascertained through self-report, which is prone to
bias. However, to mitigate this, fitness will be assessed through an objective treadmill
test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Completed |
NCT04507529 -
Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients
|
N/A | |
Recruiting |
NCT06066970 -
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
|
||
Recruiting |
NCT03620266 -
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
|
N/A | |
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
Completed |
NCT03668587 -
Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
|
||
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Recruiting |
NCT05371470 -
Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation
|
N/A | |
Recruiting |
NCT04562272 -
Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT06007950 -
Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health
|
N/A | |
Withdrawn |
NCT05327855 -
Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)
|
Phase 2 | |
Recruiting |
NCT02876952 -
High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients
|
N/A | |
Completed |
NCT02917213 -
Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
|
||
Completed |
NCT02305602 -
A Study of VentriGel in Post-MI Patients
|
Phase 1 | |
Completed |
NCT02552407 -
Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis
|
N/A | |
Completed |
NCT02382731 -
Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction
|
N/A |